Placeholder Banner

The following statement regarding today’s Cuozzo Speed Technologies, LLC v. Lee Supreme Court Decision may be attributed to the Biotechnology Innovation Organization

June 20, 2016

“Regrettably, today the Supreme Court missed an opportunity in the case of Cuozzo Speed Technologies, LLC v. Lee to reign in the United States Patent and Trademark Office’s Patent Trial and Appeal Board‘s invalidation of many patents under looser standards than would apply in federal court. 

“While we are disappointed in the Court’s ruling, it is important to note that all the Court decided today was the PTO could lawfully use the “broadest reasonable interpretation” (BRI) claim construction standard because Congress had not spoken directly to this issue in the statute.  However, the Court also made clear in its opinion that the PTO or Congress could choose to change that standard to address the policy concerns that have been raised by amici, such as BIO.  We continue to urge the PTO and Congress to do just that.  The powerful reasons to abandon the unfair BRI standard remain even after today’s decision, and the strong bipartisan votes to repeal BRI by both the House and Senate Judiciary Committees reinforce the breadth of support for that policy position.”

Discover More
First-ever BIO Clinical Trial Diversity Summit will engage stakeholders to build a sustainable and equitable clinical development ecosystem
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE”…
Collaboration has evolved for more than two decades